Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T de Witte

Showing results (31-40 of 264) with videos related to

Pageof 27
Sort By:
Leukemia|October 1, 2004
Inhibitor of apoptosis proteins: new therapeutic targets in hematological cancer?A O de Graaf, T de Witte, J H Jansen
Bone Marrow Transplantation|December 1, 1989
Intensive chemotherapy for patients with myelodysplastic syndromes and acute myelogenous leukaemia younger than 65 yearsT De Witte, P Muus, B De Pauw, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|December 24, 1997
Heme induces the expression of adhesion molecules ICAM-1, VCAM-1, and E selectin in vascular endothelial cellsF A Wagener, E Feldman, T de Witte, et al.
European Journal of Haematology|March 1, 1993
Plasma and cellular pharmacokinetics of m-AMSA related to in vitro toxicity towards normal and leukemic clonogenic bone marrow cells (CFU-GM, CFU-L)P Linssen, P Brons, G Knops, et al.
Bone Marrow Transplantation|March 1, 1989
Prevention of leukemic relapse after transplantation with lymphocyte depleted marrow by intensification of the conditioning regimen with a 6-day continuous infusion of anthracyclinesJ Raemaekers, T De Witte, A Schattenberg, et al.
Acta Haematologica|January 1, 1985
Influence of peripheral blood admixture on the number of hematopoietic progenitor cells (CFU-GM and BFU-E) in human bone marrow aspiratesT de Witte, R Holdrinet, R Raymakers, et al.
Leukemia & Lymphoma|June 1, 1994
Prognostic implications of bone marrow culturing in myelodysplastic syndrome: a retrospective analysisR Raymakers, F Preijers, J Boezeman, et al.
Bone Marrow Transplantation|July 1, 1990
Relative value of allogeneic BMT, autologous BMT and intensive chemotherapy during the first complete remission (CR) of acute myelogenous leukemia (AML). An interim analysis of the AML8 EORTC-GIMEMA protocolR Zittoun, F Mandelli, T De Witte, et al.
Bone Marrow Transplantation|April 1, 1997
Outcome of allogeneic bone marrow transplantation with lymphocyte-depleted marrow grafts in adult patients with myelodysplastic syndromesV Mattijssen, A Schattenberg, N Schaap, et al.
Vox Sanguinis|January 1, 1986
Enrichment of human bone marrow aspirates for low-density mononuclear cells using a haemonetics discontinuous blood cell separatorR Raijmakers, T de Witte, E Koekman, et al.
Pageof 27

Showing results (31-40 of 264) with videos related to

Sort By:
Pageof 27
Leukemia|October 1, 2004
Inhibitor of apoptosis proteins: new therapeutic targets in hematological cancer?A O de Graaf, T de Witte, J H Jansen
Bone Marrow Transplantation|December 1, 1989
Intensive chemotherapy for patients with myelodysplastic syndromes and acute myelogenous leukaemia younger than 65 yearsT De Witte, P Muus, B De Pauw, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|December 24, 1997
Heme induces the expression of adhesion molecules ICAM-1, VCAM-1, and E selectin in vascular endothelial cellsF A Wagener, E Feldman, T de Witte, et al.
European Journal of Haematology|March 1, 1993
Plasma and cellular pharmacokinetics of m-AMSA related to in vitro toxicity towards normal and leukemic clonogenic bone marrow cells (CFU-GM, CFU-L)P Linssen, P Brons, G Knops, et al.
Bone Marrow Transplantation|March 1, 1989
Prevention of leukemic relapse after transplantation with lymphocyte depleted marrow by intensification of the conditioning regimen with a 6-day continuous infusion of anthracyclinesJ Raemaekers, T De Witte, A Schattenberg, et al.
Acta Haematologica|January 1, 1985
Influence of peripheral blood admixture on the number of hematopoietic progenitor cells (CFU-GM and BFU-E) in human bone marrow aspiratesT de Witte, R Holdrinet, R Raymakers, et al.
Leukemia & Lymphoma|June 1, 1994
Prognostic implications of bone marrow culturing in myelodysplastic syndrome: a retrospective analysisR Raymakers, F Preijers, J Boezeman, et al.
Bone Marrow Transplantation|July 1, 1990
Relative value of allogeneic BMT, autologous BMT and intensive chemotherapy during the first complete remission (CR) of acute myelogenous leukemia (AML). An interim analysis of the AML8 EORTC-GIMEMA protocolR Zittoun, F Mandelli, T De Witte, et al.
Bone Marrow Transplantation|April 1, 1997
Outcome of allogeneic bone marrow transplantation with lymphocyte-depleted marrow grafts in adult patients with myelodysplastic syndromesV Mattijssen, A Schattenberg, N Schaap, et al.
Vox Sanguinis|January 1, 1986
Enrichment of human bone marrow aspirates for low-density mononuclear cells using a haemonetics discontinuous blood cell separatorR Raijmakers, T de Witte, E Koekman, et al.
Pageof 27